[2019-nCoV: new challenges from coronavirus].
Identifieur interne : 000057 ( Main/Exploration ); précédent : 000056; suivant : 000058[2019-nCoV: new challenges from coronavirus].
Auteurs : H Y Tian [République populaire de Chine]Source :
- Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [ 0253-9624 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Betacoronavirus (isolation & purification), Betacoronavirus (pathogenicity), Biomedical Research, China, Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Disease Outbreaks, Humans, Pandemics, Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Population Surveillance.
- MESH :
- geographic : China.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- pathogenicity : Betacoronavirus.
- prevention & control : Coronavirus Infections, Pneumonia, Viral.
- Biomedical Research, Disease Outbreaks, Humans, Pandemics, Population Surveillance.
Abstract
The outbreak of pneumonia caused by the novel coronavirus (2019-nCoV) in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the β genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.
DOI: 10.3760/cma.j.issn.0253-9624.2020.03.002
PubMed: 32187929
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000588
- to stream PubMed, to step Curation: 000588
- to stream PubMed, to step Checkpoint: 000043
- to stream Ncbi, to step Merge: 003426
- to stream Ncbi, to step Curation: 003426
- to stream Ncbi, to step Checkpoint: 003426
- to stream Main, to step Merge: 000057
- to stream PubMed, to step Corpus: 000814
- to stream PubMed, to step Curation: 000814
- to stream PubMed, to step Checkpoint: 000042
- to stream Ncbi, to step Merge: 003157
- to stream Ncbi, to step Curation: 003157
- to stream Ncbi, to step Checkpoint: 003157
- to stream Main, to step Merge: 000056
- to stream Main, to step Curation: 000057
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[2019-nCoV: new challenges from coronavirus].</title>
<author><name sortKey="Tian, H Y" sort="Tian, H Y" uniqKey="Tian H" first="H Y" last="Tian">H Y Tian</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32187929</idno>
<idno type="pmid">32187929</idno>
<idno type="doi">10.3760/cma.j.issn.0253-9624.2020.03.002</idno>
<idno type="wicri:Area/PubMed/Corpus">000588</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000588</idno>
<idno type="wicri:Area/PubMed/Curation">000588</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000588</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000043</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000043</idno>
<idno type="wicri:Area/Ncbi/Merge">003426</idno>
<idno type="wicri:Area/Ncbi/Curation">003426</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003426</idno>
<idno type="wicri:doubleKey">0253-9624:2020:Tian H:ncov:new:challenges</idno>
<idno type="wicri:Area/Main/Merge">000057</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:32023682</idno>
<idno type="wicri:Area/PubMed/Corpus">000814</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000814</idno>
<idno type="wicri:Area/PubMed/Curation">000814</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000814</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000042</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000042</idno>
<idno type="wicri:Area/Ncbi/Merge">003157</idno>
<idno type="wicri:Area/Ncbi/Curation">003157</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003157</idno>
<idno type="wicri:doubleKey">0253-9624:2020:Tian H:ncov:new:challenges</idno>
<idno type="wicri:Area/Main/Merge">000056</idno>
<idno type="wicri:Area/Main/Curation">000057</idno>
<idno type="wicri:Area/Main/Exploration">000057</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[2019-nCoV: new challenges from coronavirus].</title>
<author><name sortKey="Tian, H Y" sort="Tian, H Y" uniqKey="Tian H" first="H Y" last="Tian">H Y Tian</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</title>
<idno type="ISSN">0253-9624</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>Biomedical Research</term>
<term>China</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Population Surveillance</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Chine</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Pandémies</term>
<term>Pneumopathie virale ()</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Recherche biomédicale</term>
<term>Surveillance de la population</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Biomedical Research</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Population Surveillance</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chine</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Recherche biomédicale</term>
<term>Surveillance de la population</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The outbreak of pneumonia caused by the novel coronavirus (2019-nCoV) in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the β genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Tian, H Y" sort="Tian, H Y" uniqKey="Tian H" first="H Y" last="Tian">H Y Tian</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32187929 |texte= [2019-nCoV: new challenges from coronavirus]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32187929" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |